Expert Review of Medical Devices, Journal Year: 2024, Volume and Issue: 21(10), P. 927 - 941
Published: Oct. 2, 2024
Hybrid closed loop systems are now commercially available for people with type 1 diabetes and increasingly being adopted into clinical practice. Real-world data reflect both the glycemic quality of life benefits reported in trials.
Language: Английский
Journal of Clinical Medicine, Journal Year: 2025, Volume and Issue: 14(2), P. 383 - 383
Published: Jan. 9, 2025
Type 1 Diabetes (T1D) is a progressive autoimmune disease often identified in childhood or adolescence, with early stages detectable through pre-diabetic markers such as autoantibodies and subclinical beta-cell dysfunction. The identification of the pre-T1D stage critical for preventing complications, diabetic ketoacidosis, enabling timely interventions that may alter progression. This review examines multifaceted approach to managing T1D risk adolescents teens, emphasizing detection, nutritional interventions, preservation strategies, psychosocial support. Screening T1D-associated offers predictive insight into risk, particularly when combined education family resources promote lifestyle adjustments. Although alone are not capable T1D, certain weight management specific choices, have shown potential preserve insulin sensitivity, reduce inflammation, mitigate metabolic strain. Pharmacological including immune-modulating drugs like teplizumab, alongside emerging regenerative cell-based therapies, offer delay onset by protecting function. social psychological impacts diagnosis also significant, affecting adolescents' quality life, dynamics, mental health. Supportive counseling, cognitive-behavioral therapy (CBT), group support, recommended emotional burden pre-diabetes. Future directions call integrating universal targeted screening programs within schools primary care, advancing research nutrition promoting policies enhance access preventive resources. Advocacy insurance coverage screening, health services crucial support families risk. By addressing these areas, healthcare systems can intervention, improve preservation, overall well-being at T1D.
Language: Английский
Citations
1
PLoS ONE, Journal Year: 2025, Volume and Issue: 20(4), P. e0321090 - e0321090
Published: April 15, 2025
As the prevalence of diabetes increases among elderly population, effective management becomes increasingly crucial. IoT mobile applications offer promising solutions for care by providing real-time monitoring, medication management, and lifestyle support. This paper aims to investigate potential challenges in managing patients. Three databases including Scopus, Web Science, IEEE were systematically searched; 29 articles screened final analysis process. Key results indicate that application apps includes blood glucose adherence, promotion physical activity, dietary control. Devices such as continuous monitors smart pill dispensers significantly improve glycemic control adherence rates, these technologies enable tracking, personalized feedback, timely interventions, which enhance self-management communication with healthcare providers. However, technical like interoperability, data security privacy, usability involvement policymakers pose significant barriers their implementation. Collaborative efforts from providers, device manufacturers, are essential overcome fully leverage benefits diabetic care. review highlights need collaborative develop standardized frameworks ensure compatibility seamless integration care, privacy advanced technology, design user-friendly generalization adoption fields elderly.
Language: Английский
Citations
0
Journal of Molecular Liquids, Journal Year: 2024, Volume and Issue: unknown, P. 126117 - 126117
Published: Sept. 1, 2024
Language: Английский
Citations
2
Expert Review of Medical Devices, Journal Year: 2024, Volume and Issue: 21(10), P. 927 - 941
Published: Oct. 2, 2024
Hybrid closed loop systems are now commercially available for people with type 1 diabetes and increasingly being adopted into clinical practice. Real-world data reflect both the glycemic quality of life benefits reported in trials.
Language: Английский
Citations
2